TY - JOUR
T1 - Diagnostic challenges in the assessment of thyroid neoplasms using nuclear features and vascular and capsular invasion
T2 - a multi-center interobserver agreement study
AU - Harahap, Agnes Stephanie
AU - Mutmainnah, Mutiah
AU - Ham, Maria Francisca
AU - Khoirunnisa, Dina
AU - Assadyk, Abdillah Hasbi
AU - Cangara, Husni
AU - Asri, Aswiyanti
AU - Retnani, Diah Prabawati
AU - Quzwain, Fairuz
AU - Agustina, Hasrayati
AU - Istiadi, Hermawan
AU - Windarti, Indri
AU - Murti, Krisna
AU - Takbir, Muhammad
AU - Mahastuti, Ni Made
AU - Kurniasari, Nila
AU - Anggorowati, Nungki
AU - Abineno, Pamela
AU - Setyorini, Yulita Pundewi
AU - Kakudo, Kennichi
N1 - Publisher Copyright:
© 2024 The Korean Society of Pathologists/The Korean Society for Cytopathology.
PY - 2024/11
Y1 - 2024/11
N2 - Background: The diagnosis of thyroid neoplasms necessitates the identification of distinct histological features. Various education/hospital centers located in cities across Indonesia likely result in discordances among pathologists when diagnosing thyroid neoplasms. Methods: This study examined the concordance among Indonesian pathologists in assessing nuclear features and capsular and vascular invasion of thyroid tumors. Fifteen pathologists from different centers independently assessed the same 14 digital slides of thyroid tumor specimens. All the specimens were thyroid neoplasms with known BRAFV600E and RASmutational status, from a single center. We evaluated the pre- and post-training agreement using the Fleiss kappa. The significance of the training was evaluated using a paired T-test. Results: Baseline agreement on nuclear features was slight to fair based on a 3-point scoring system (k=0.14 to 0.28) and poor to fair based on an eight-point system (k=–0.02 to 0.24). Agreements on vascular (κ=0.35) and capsular invasion (κ=0.27) were fair, whereas the estimated molecular type showed substantial agreement (κ=0.74). Following the training, agreement using the eight-point system significantly improved (p=0.001). Conclusions: The level of concordance among Indonesian pathologists in diagnosing thyroid neoplasm was relatively poor. Consensus in pathology assessment requires ongoing collaboration and education to refine diagnostic criteria.
AB - Background: The diagnosis of thyroid neoplasms necessitates the identification of distinct histological features. Various education/hospital centers located in cities across Indonesia likely result in discordances among pathologists when diagnosing thyroid neoplasms. Methods: This study examined the concordance among Indonesian pathologists in assessing nuclear features and capsular and vascular invasion of thyroid tumors. Fifteen pathologists from different centers independently assessed the same 14 digital slides of thyroid tumor specimens. All the specimens were thyroid neoplasms with known BRAFV600E and RASmutational status, from a single center. We evaluated the pre- and post-training agreement using the Fleiss kappa. The significance of the training was evaluated using a paired T-test. Results: Baseline agreement on nuclear features was slight to fair based on a 3-point scoring system (k=0.14 to 0.28) and poor to fair based on an eight-point system (k=–0.02 to 0.24). Agreements on vascular (κ=0.35) and capsular invasion (κ=0.27) were fair, whereas the estimated molecular type showed substantial agreement (κ=0.74). Following the training, agreement using the eight-point system significantly improved (p=0.001). Conclusions: The level of concordance among Indonesian pathologists in diagnosing thyroid neoplasm was relatively poor. Consensus in pathology assessment requires ongoing collaboration and education to refine diagnostic criteria.
KW - Observer variation
KW - Papillary thyroid cancer
KW - Thyroid neoplasms
UR - http://www.scopus.com/inward/record.url?scp=85210753225&partnerID=8YFLogxK
U2 - 10.4132/jptm.2024.07.25
DO - 10.4132/jptm.2024.07.25
M3 - Article
AN - SCOPUS:85210753225
SN - 2383-7837
VL - 58
SP - 299
EP - 309
JO - Journal of Pathology and Translational Medicine
JF - Journal of Pathology and Translational Medicine
IS - 6
ER -